We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Nasal Spray Provides Rapid Pain Relief for Children in Emergency Care

By HospiMedica International staff writers
Posted on 30 Sep 2026

Pain in children treated in emergency departments can be difficult to control quickly, and inadequate analgesia may increase distress for both patients and families during urgent care. More...

Treatment options can be limited, while some approaches require injections that may add further discomfort. A new study now shows that a nasal spray treatment may provide rapid, needle-free pain relief for pediatric emergency patients.

The research was conducted through Sheffield Children’s Hospital, the University of Sheffield, and Sheffield Hallam University in the UK. The study evaluated a nasal spray combining two analgesic medications, sufentanil and ketamine, with dosing adjusted to each child’s weight by varying the number of sprays administered. The approach was designed to provide a simple, weight-based dosing system for children experiencing moderate to severe pain.

The study included 152 children ages one to 17 years who were treated at seven hospital emergency departments in the UK and Spain between May 2024 and May 2025. Most children had limb injuries, including fractures and dislocations. Other participants had burns or soft tissue injuries. Pain levels and side effects were assessed at 15 minutes and 30 minutes after treatment using standard assessments.

The findings were presented at the European Emergency Medicine Congress (EUSEM 2026). After 15 minutes, 54% of children had less pain. After 30 minutes, 88% had less pain, and pain was reduced by around half in 86.2% of children. Reported side effects were mild and included nausea or vomiting, dizziness and nasal itching.

The nasal spray was tested for the European Medicines Agency pediatric-use marketing authorization scheme, which is intended to encourage manufacturers to develop and adapt medications specifically for children. The treatment is expected to become available for use in Europe in the near future.

“Our research shows that this drug can provide rapid and meaningful pain relief for children being treated in the emergency department. Children tolerated the nose spray well with no major side effects. This is good news for children and their families. This also gives doctors a simple and effective option for treating their patients where very few options currently exist,” said Shammi Ramlakhan, an emergency medicine consultant working at Sheffield Children’s Hospital, the University of Sheffield and Sheffield Hallam University in the UK.

Related Links
University of Sheffield
Sheffield Hallam University


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Immobilization System
Cranial 4Pi Immobilization
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.